Study designed to investigate the efficacy and safety of ISA101b added to checkpoint inhibitor therapy in Human Papilloma Virus type 16 (HPV16) induced oropharyngeal cancer (OPC). Trial is part of an ...
Whether it's jumping over a canyon in a rocket-powered motorcycle, running with the bulls, or taking a selfie while leaning out of a fast-moving train, people will do insanely risky things to prove ...
Despite the common misconception that COVID-19 primarily has negative effects on society, it may not be difficult to ...
Highlights: Opioid overdose is an alarming issue worldwide with over 107,622 overdose deaths in 2021; People engaging in ...
Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion ...
STIMULAN gives surgeons the freedom to choose and combine the antibiotics that support their infection treatment strategy KEELE, England, Nov. /PRNewswire/ -- Biocomposites, an international medical ...
Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10-year risk of death from a heart attack or stroke, stemming from atherosclerotic cardiovascular disease ...
CHICAGO, Nov. 29, 2022 /PRNewswire/ -- Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that corticosteroid injections were associated with the ...
CHICAGO, Nov. 29, 2022 /PRNewswire/ -- One in five women is likely to forgo additional testing after an abnormal finding on a screening mammogram if there is a deductible, according to a new study ...
Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health. Each year, the prize will ...
Prioritizing a limited supply of vaccines to subpopulations with a higher transmission risk can minimize transmission.
A computer-based platform for drug development designed by researchers from The University of Texas at Dallas and Novartis ...